Selected research
Market Structure
Global Intestinal Ascariasis Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Intestinal Ascariasis Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Intestinal Ascariasis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Intestinal Ascariasis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Intestinal Ascariasis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Intestinal Ascariasis Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Intestinal Ascariasis Medicine include Actavis, Bayer HealthCare, Bullvet, Cipla, Endo Pharmaceuticals, Henan Sino New Energy Material, Inject Care Parenterals, Purdue Pharma and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Intestinal Ascariasis Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Intestinal Ascariasis Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Intestinal Ascariasis Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Intestinal Ascariasis Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Intestinal Ascariasis Medicine Segment by Company
Actavis
Bayer HealthCare
Bullvet
Cipla
Endo Pharmaceuticals
Henan Sino New Energy Material
Inject Care Parenterals
Purdue Pharma
Pfizer
Novartis
Johnson & Johnson
Sanofi
Sun Pharmaceutical Industries
Intestinal Ascariasis Medicine Segment by Type
Painkiller
Piperazine Citrate
Complication Treatment Drug
Others
Intestinal Ascariasis Medicine Segment by Application
Patients With Ulcer Disease
Complication Treatment
Others
Intestinal Ascariasis Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Ascariasis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intestinal Ascariasis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Ascariasis Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Intestinal Ascariasis Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Intestinal Ascariasis Medicine industry.
Chapter 3: Detailed analysis of Intestinal Ascariasis Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intestinal Ascariasis Medicinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Painkiller
- Piperazine Citrate
- Complication Treatment Drug
- Others
Applications
- Patients With Ulcer Disease
- Complication Treatment
- Others
Companies covered
- Actavis
- Bayer HealthCare
- Bullvet
- Cipla
- Endo Pharmaceuticals
- Henan Sino New Energy Material
- Inject Care Parenterals
- Purdue Pharma
- Pfizer
- Novartis
- Johnson & Johnson
- Sanofi
- Sun Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Painkiller
- 1.2.3 Piperazine Citrate
- 1.2.4 Complication Treatment Drug
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Intestinal Ascariasis Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Patients With Ulcer Disease
- 1.3.3 Complication Treatment
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Intestinal Ascariasis Medicine Growth Trends by Region
- 1.5.1 Global Intestinal Ascariasis Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Intestinal Ascariasis Medicine Market Size by Region (2021-2026)
- 1.5.3 Intestinal Ascariasis Medicine Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Intestinal Ascariasis Medicine Market Dynamics
- 2.1 Intestinal Ascariasis Medicine Industry Trends
- 2.2 Intestinal Ascariasis Medicine Industry Drivers
- 2.3 Intestinal Ascariasis Medicine Industry Opportunities and Challenges
- 2.4 Intestinal Ascariasis Medicine Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Intestinal Ascariasis Medicine Revenue by Company (2021-2026)
- 3.2 Global Intestinal Ascariasis Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Intestinal Ascariasis Medicine Key Company Head office and Area Served
- 3.4 Global Intestinal Ascariasis Medicine Company, Product Type & Application
- 3.5 Global Intestinal Ascariasis Medicine Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Intestinal Ascariasis Medicine Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Intestinal Ascariasis Medicine Players Market Share by Revenue in 2025
- 3.6.3 2025 Intestinal Ascariasis Medicine Tier 1, Tier 2, and Tier 3
4 Intestinal Ascariasis Medicine Market by Type
- 4.1 Global Intestinal Ascariasis Medicine Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Intestinal Ascariasis Medicine Market Size by Type (2021-2032)
- 4.3 Global Intestinal Ascariasis Medicine Market Size Share by Type (2021-2032)
5 Intestinal Ascariasis Medicine Market by Application
- 5.1 Global Intestinal Ascariasis Medicine Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Intestinal Ascariasis Medicine Market Size by Application (2021-2032)
- 5.3 Global Intestinal Ascariasis Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Actavis
- 6.1.1 Actavis Company Information
- 6.1.2 Actavis Business Overview
- 6.1.3 Actavis Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Actavis Intestinal Ascariasis Medicine Product Portfolio
- 6.1.5 Actavis Recent Developments
- 6.2 Bayer HealthCare
- 6.2.1 Bayer HealthCare Company Information
- 6.2.2 Bayer HealthCare Business Overview
- 6.2.3 Bayer HealthCare Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Bayer HealthCare Intestinal Ascariasis Medicine Product Portfolio
- 6.2.5 Bayer HealthCare Recent Developments
- 6.3 Bullvet
- 6.3.1 Bullvet Company Information
- 6.3.2 Bullvet Business Overview
- 6.3.3 Bullvet Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bullvet Intestinal Ascariasis Medicine Product Portfolio
- 6.3.5 Bullvet Recent Developments
- 6.4 Cipla
- 6.4.1 Cipla Company Information
- 6.4.2 Cipla Business Overview
- 6.4.3 Cipla Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Cipla Intestinal Ascariasis Medicine Product Portfolio
- 6.4.5 Cipla Recent Developments
- 6.5 Endo Pharmaceuticals
- 6.5.1 Endo Pharmaceuticals Company Information
- 6.5.2 Endo Pharmaceuticals Business Overview
- 6.5.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Endo Pharmaceuticals Intestinal Ascariasis Medicine Product Portfolio
- 6.5.5 Endo Pharmaceuticals Recent Developments
- 6.6 Henan Sino New Energy Material
- 6.6.1 Henan Sino New Energy Material Company Information
- 6.6.2 Henan Sino New Energy Material Business Overview
- 6.6.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Henan Sino New Energy Material Intestinal Ascariasis Medicine Product Portfolio
- 6.6.5 Henan Sino New Energy Material Recent Developments
- 6.7 Inject Care Parenterals
- 6.7.1 Inject Care Parenterals Company Information
- 6.7.2 Inject Care Parenterals Business Overview
- 6.7.3 Inject Care Parenterals Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Inject Care Parenterals Intestinal Ascariasis Medicine Product Portfolio
- 6.7.5 Inject Care Parenterals Recent Developments
- 6.8 Purdue Pharma
- 6.8.1 Purdue Pharma Company Information
- 6.8.2 Purdue Pharma Business Overview
- 6.8.3 Purdue Pharma Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Purdue Pharma Intestinal Ascariasis Medicine Product Portfolio
- 6.8.5 Purdue Pharma Recent Developments
- 6.9 Pfizer
- 6.9.1 Pfizer Company Information
- 6.9.2 Pfizer Business Overview
- 6.9.3 Pfizer Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Pfizer Intestinal Ascariasis Medicine Product Portfolio
- 6.9.5 Pfizer Recent Developments
- 6.10 Novartis
- 6.10.1 Novartis Company Information
- 6.10.2 Novartis Business Overview
- 6.10.3 Novartis Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Novartis Intestinal Ascariasis Medicine Product Portfolio
- 6.10.5 Novartis Recent Developments
- 6.11 Johnson & Johnson
- 6.11.1 Johnson & Johnson Company Information
- 6.11.2 Johnson & Johnson Business Overview
- 6.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Johnson & Johnson Intestinal Ascariasis Medicine Product Portfolio
- 6.11.5 Johnson & Johnson Recent Developments
- 6.12 Sanofi
- 6.12.1 Sanofi Company Information
- 6.12.2 Sanofi Business Overview
- 6.12.3 Sanofi Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Sanofi Intestinal Ascariasis Medicine Product Portfolio
- 6.12.5 Sanofi Recent Developments
- 6.13 Sun Pharmaceutical Industries
- 6.13.1 Sun Pharmaceutical Industries Company Information
- 6.13.2 Sun Pharmaceutical Industries Business Overview
- 6.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product Portfolio
- 6.13.5 Sun Pharmaceutical Industries Recent Developments
7 North America
- 7.1 North America Intestinal Ascariasis Medicine Market Size (2021-2032)
- 7.2 North America Intestinal Ascariasis Medicine Market Size by Type
- 7.2.1 North America Intestinal Ascariasis Medicine Market Size by Type (2021-2026)
- 7.2.2 North America Intestinal Ascariasis Medicine Market Size by Type (2027-2032)
- 7.2.3 North America Intestinal Ascariasis Medicine Market Share by Type (2021-2032)
- 7.3 North America Intestinal Ascariasis Medicine Market Size by Application
- 7.3.1 North America Intestinal Ascariasis Medicine Market Size by Application (2021-2026)
- 7.3.2 North America Intestinal Ascariasis Medicine Market Size by Application (2027-2032)
- 7.3.3 North America Intestinal Ascariasis Medicine Market Share by Application (2021-2032)
- 7.4 North America Intestinal Ascariasis Medicine Market Size by Country
- 7.4.1 North America Intestinal Ascariasis Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 7.4.3 North America Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 7.4.4 North America Intestinal Ascariasis Medicine Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Intestinal Ascariasis Medicine Market Size (2021-2032)
- 8.2 Europe Intestinal Ascariasis Medicine Market Size by Type
- 8.2.1 Europe Intestinal Ascariasis Medicine Market Size by Type (2021-2026)
- 8.2.2 Europe Intestinal Ascariasis Medicine Market Size by Type (2027-2032)
- 8.2.3 Europe Intestinal Ascariasis Medicine Market Share by Type (2021-2032)
- 8.3 Europe Intestinal Ascariasis Medicine Market Size by Application
- 8.3.1 Europe Intestinal Ascariasis Medicine Market Size by Application (2021-2026)
- 8.3.2 Europe Intestinal Ascariasis Medicine Market Size by Application (2027-2032)
- 8.3.3 Europe Intestinal Ascariasis Medicine Market Share by Application (2021-2032)
- 8.4 Europe Intestinal Ascariasis Medicine Market Size by Country
- 8.4.1 Europe Intestinal Ascariasis Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 8.4.3 Europe Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 8.4.4 Europe Intestinal Ascariasis Medicine Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Intestinal Ascariasis Medicine Market Size (2021-2032)
- 9.2 China Intestinal Ascariasis Medicine Market Size by Type
- 9.2.1 China Intestinal Ascariasis Medicine Market Size by Type (2021-2026)
- 9.2.2 China Intestinal Ascariasis Medicine Market Size by Type (2027-2032)
- 9.2.3 China Intestinal Ascariasis Medicine Market Share by Type (2021-2032)
- 9.3 China Intestinal Ascariasis Medicine Market Size by Application
- 9.3.1 China Intestinal Ascariasis Medicine Market Size by Application (2021-2026)
- 9.3.2 China Intestinal Ascariasis Medicine Market Size by Application (2027-2032)
- 9.3.3 China Intestinal Ascariasis Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Intestinal Ascariasis Medicine Market Size (2021-2032)
- 10.2 Asia Intestinal Ascariasis Medicine Market Size by Type
- 10.2.1 Asia Intestinal Ascariasis Medicine Market Size by Type (2021-2026)
- 10.2.2 Asia Intestinal Ascariasis Medicine Market Size by Type (2027-2032)
- 10.2.3 Asia Intestinal Ascariasis Medicine Market Share by Type (2021-2032)
- 10.3 Asia Intestinal Ascariasis Medicine Market Size by Application
- 10.3.1 Asia Intestinal Ascariasis Medicine Market Size by Application (2021-2026)
- 10.3.2 Asia Intestinal Ascariasis Medicine Market Size by Application (2027-2032)
- 10.3.3 Asia Intestinal Ascariasis Medicine Market Share by Application (2021-2032)
- 10.4 Asia Intestinal Ascariasis Medicine Market Size by Country
- 10.4.1 Asia Intestinal Ascariasis Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 10.4.3 Asia Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 10.4.4 Asia Intestinal Ascariasis Medicine Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type
- 11.2.1 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application
- 11.3.1 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country
- 11.4.1 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Intestinal Ascariasis Medicine Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst